相关实验视频

Updated: May 26, 2025

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

标准剂量可以更好! 在肝衰竭患者中对tigecycline的多中心研究

Jinlin Guo¹, Xinfeng Cai², Shan Wang³

¹Department of Pharmacy, Shanxi Provincial People's Hospital, Taiyuan, Shanxi, China.

Expert review of anti-infective therapy

|February 24, 2025

概括

标准剂量的tigecycline在肝衰竭患者的严重感染中有效,平衡微生物根除和安全性. 这种剂量优于标签剂量或高剂量疗法,减少不良事件和死亡风险.

科学领域:

药理学药理学是指药理学的学科.
传染性疾病传染性疾病
肝病学肝病学是一种肝病学.

背景情况:

严重的多药耐药格拉姆阴性感染需要高剂量的tigecycline在肝衰竭患者.
标准的tigecycline剂量指南建议在严重肝功能障碍的情况下减少剂量.
这项研究调查了儿童-皮格等级C肝衰竭中tigecycline的剂量.

研究的目的:

评估不同剂量的tigecycline在患有严重肝功能衰竭的患者中的疗效和安全性.
在各种剂量策略中比较微生物根除率和不良事件.
为了确定在这个患者群体中管理严重感染的最佳tigecycline剂量.

主要方法:

对192名患有Child-Pugh等级C肝衰竭的患者进行了回顾性队列研究.
患者被分为标签剂量 (LD),标准剂量 (SD) 和高剂量 (HD) 的tigecycline组.
评估结果包括微生物根除,死亡率和不良影响.

主要成果:

标准剂量 (SD) 提格环素显示出比标签剂量 (LD) 更高的微生物根除.
SDtigecycline的疗效与高剂量 (HD) 相似,但不良事件较少,包括减少对纤维素原的需求.
高剂量 (HD) 环素与增加的死亡风险有关 (危险比:1.85,p=0.062).

结论:

标准剂量 (SD) 提格环素在细菌根除和肝衰竭患者安全之间提供了最佳的平衡.
在患有Child-Pugh等级C肝衰竭的患者中,SDtigecycline是管理严重感染的首选方案.
用SDtigecycline治疗7天的治疗时间似乎是最佳的疗效和安全性.

关键词:

儿童-皮格 C C 肝功能衰竭肝功能衰竭肝功能衰竭消灭微生物的消灭.死亡率死亡率多种耐药性感染的多重耐药性感染.这种药物是tigecycline.

更多相关视频

Fluorescent Laparoscopic Central Hepatectomy for Liver Cancer Using Indocyanine Green Negative Staining

Fluorescent Laparoscopic Central Hepatectomy for Liver Cancer Using Indocyanine Green Negative Staining

Published on: March 17, 2023

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride CCl4 Exposure Through an Orogastric Tube

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride CCl4 Exposure Through an Orogastric Tube

Published on: April 28, 2020

相关概念视频

Renal Failure: Dose Adjustments

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...